Skip to main content
Download PDF

Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea

Annals of Clinical Microbiology and Antimicrobials volume 22, Article number: 76 (2023) Cite this article

Abstract

Background

The emergence of carbapenem-resistant Enterobacterales (CRE) infections is rapidly increasing and represents a serious public threat. In 2020, a total of 16,883 carbapenemase-producing Enterobacterales strains were collected; among these isolates, 21 strains were repeatedly isolated in a local tertiary care hospital.

Methods

Antimicrobial susceptibility testing was performed using the broth microdilution method. All 21 strains of CRKP were analyzed by PFGE after XbaI digestion. The 21 CRKP strains were sequenced on the Illumina Miseq and Oxford Nanopore GridION platforms.

Results

These 21 CRKP isolates showed an identical antimicrobial resistance profile, including resistance to ampicillin, carbapenems, cephems, chloramphenicol, fluoroquinolone, macrolides and trimethoprim/sulfamethoxazole. Based on whole-genome analysis, these 21 CRKP isolates shared a common genetic structure (ISAba125-IS630-blaNDM−1-bleMBL) and harbored additional resistance determinants (blaOXA−1, blaCTX−M−15, blaSHV−11, blaSHV−67, aac(6’)-Ib-cr, qnrS1, OqxA, OqxB, catB3, mph(A), sul1, and dfrA12) and mutations in the quinolone resistance-determining regions of gyrA (S83I) and parC (S80I). These isolates belonged to the ST147 and KL64 capsular types, which were carried on IncFIB replicon plasmids. The 21 CRKP strains collected from one hospital were divided into five PFGE patterns, and they were closely related with a minimum similarity value of 95.2%. These isolates were found to be highly related based on the presence of between 2 and 27 SNPs.

Conclusions

These findings indicate that NDM-1-producing K. pneumoniae ST147 may have been introduced via a common source, implying nosocomial transmission; furthermore, continuous monitoring is necessary to prevent endemic transmission.

Background

The emergence of carbapenem-resistant Enterobacterales (CRE) infections is rapidly accelerating and represents a serious public threat. Recently, among CRE infectious agents, Klebsiella pneumoniae has become one of the most common causative pathogens of hospital- and community-acquired infections in the Republic of Korea [1]. Additionally, the predominant carbapenemase genes associated with K. pneumoniae infections are K. pneumoniae carbapenemase (KPC), followed by New Delhi metallo-β-lactamase (NDM), which was reported in a previous study [2]. Carbapenem-resistant K. pneumoniae has a significant influence on endemic transmission.

Since the first published records from Hungary and Spain in 2008 and 2009, respectively [3, 4]. Previous reports have indicated the dissemination of the K. pneumoniae, especially, specific sequence types or clones, including ST147, that are related with dissemination and success of carbapenem-resistant K. pneumoniae; these strains are classified as high-risk STs or clones [5, 6]. Also, several studies have reported the dissemination of high-risk clones of carbapenem-resistant K. pneumoniae [7,8,9,10]. K. pneumoniae ST147 is an emerging high-risk clone because of its successful acquisition of multidrug resistance and high transmissibility, both of which are an important vehicle for dissemination [5].

The Korea Disease Control and Prevention Agency (KDCA) has collected and tested all CRE isolates to monitor antimicrobial resistance profiles and the associated resistance genes by the Korean Antimicrobial Resistance Monitoring System. We confirmed that persistent infections caused by NDM-1-producing K. pneumoniae ST147 occurred in a local tertiary care hospital in the Republic of Korea. In this study, we elucidate the molecular and epidemiological characterization of NDM-1-producing K. pneumoniae ST147 isolates.

Methods

Bacterial isolates

In 2020, a total of 16,883 carbapenemase-producing Enterobacterales strains were collected from local public health laboratories, including tertiary care hospitals and long-term care hospitals. The bacterial species were confirmed using a VITEK 2 automated system (bioMérieux, Marcy l’Etoile, France) with a VITEK®2 GN ID card. All isolates were screened by PCR sequencing for the presence of carbapenemase genes (blaNDM, blaKPC, blaIMP, blaVIM, blaOXA and blaGES), as described previously [11]. 9,234 (54.7%) of isolates were confirmed to be carbapenem-resistant Enterobacterales. The most prevalent CRE species detected were the Klebsiella pneumoniae (n = 6,254, 67.7%), followed by Escherichia coli (n = 1,591, 17.2%) and Enterobacter cloacae (n = 337, 3.6%). The following carbapenemase genes were identified: blaKPC− 2 (n = 5,511, 75.6%), blaNDM− 1 (n = 878, 12%), blaNDM− 5 (n = 285, 3.9%) and blaOXA− 181 (n = 167, 2.3%). Among these isolates, only 496 strains (5.4%) were identified as NDM-1-producing K. pneumoniae and these strains were sporadically isolated from separate regions in distinct hospitals. During this period, we found that only 21 NDM-producing K. pneumoniae were persistently isolated from a single hospital between June and December. In this process, we found that 21 carbapenem-resistant K. pneumoniae (CRKP) strains were persistently isolated from a local tertiary care hospital. We have selected the 21 isolates for analysis of their molecular epidemiology associations.

Antimicrobial susceptibility testing and conjugation assay

Antimicrobial susceptibility testing was performed using the broth microdilution method with customized Sensititre KRCDC2F and KORN panels (TREK Diagnostic Systems, United Kingdom) in accordance with the guidelines established by the Clinical and Laboratory Standards Institute (CLSI) [12]. The antimicrobial agents tested were ampicillin, cephems, carbapenems, fluoroquinolone, gentamicin, streptomycin, tetracycline, trimethoprim/sulfamethoxazole and chloramphenicol. Conjugal transfer of carbapenem resistance genes were examined using azide-resistant E. coli J53 as the recipient strain. 21 blaNDM−1 positive CRKP isolates were selected for this assay. Donor and recipient cells from Luria-Bertani broth cultures were mixed in a ratio of 1:5 and transconjugants were selected on MacConkey agar plates (Difco, USA) supplemented with imipenem (1 mg/L) and sodium azide (200 mg/L). Carriage of blaNDM–1 in the transconjugant was confirmed by PCR and MICs.

Pulsed-field gel electrophoresis (PFGE)

All 21 strains of CRKP were analyzed by pulsed-field gel electrophoresis (PFGE) after XbaI digestion according to the PulseNet International protocol (https://pulsenetinternational.org/). The genetic relatedness between PFGE patterns was calculated by using BioNumerics v7.6 (Applied Maths, Sint-Martens-Latem, Belgium).

Whole-genome sequencing (WGS)

Genomic DNA of the 21 isolates was isolated using a Blood and Tissue Kit (Qiagen, Stockach, Germany) according to the manufacturer’s protocol. Short-read DNA libraries were prepared using an Illumina Nextera Flex library preparation kit and sequenced on a MiSeq sequencer (Illumina, San Diego, CA, USA). A long-read GridION sequencing library was prepared by using a ligation sequencing kit (SQK-LSK109), and sequencing was carried out using a version R9.4.1 flow cell (FLO-MIN 106D).

WGS analysis

The contigs of genomic sequences were assembled with a minimum contig size threshold of 200 bp using the de novo assembly tool within the CLC genomic workbench 21.0.3. Assembled sequences were analyzed for resistance genes (ResFinder 4.1), sequence type (MLST 2.0) and plasmid replicon types (PlasmidFinder 2.1) using bioinformatics web tools available from the Center for Genomic Epidemiology (CGE) website (https://www.genomicepidemiology.org/). The capsular type and virulence genes of these isolates were confirmed using the Bacterial Isolate Genome Sequence Database (https://bigsdb.pasteur.fr/klebsiella/). Single-nucleotide polymorphisms (SNPs) of the 21 CRKP isolates were identified using CSI phylogeny 1.4 (https://cge.food.dtu.dk/services/CSIPhylogeny/) by comparison with the reference strain K. pneumoniae KP5 (GenBank accession no. CP012426) [13]. The phylogenetic analysis was performed by aligning the whole genome of K. pneumoniae KP5 with the whole genomes of other representative NDM-producing K. pneumoniae strains available in the GenBank database (Table S1).

Nucleotide sequence accession numbers

The whole-genome sequences of these strains were deposited with the National Center for Biotechnology Information (NCBI) under the Bio-Project PRJNA813961. The two plasmids sequences were submitted to the GenBank database and can be found under accession numbers OQ785270-OQ785271.

Results

Characteristics of bacterial isolates

Among the isolates, 21 CRKP strains were continuously isolated from June to December in a local tertiary care hospital; 10 were from sputum samples, 4 from urine samples, 3 from wound swabs, 2 from abscess samples and 1 each from a rectal swab and a bronchial washing fluid. Antimicrobial susceptibility testing showed that the 21 CRKP isolates were resistant to ampicillin, carbapenems, cephems, chloramphenicol, fluoroquinolone, macrolides and trimethoprim/sulfamethoxazole, whereas all isolates were susceptible to amikacin, colistin, gentamicin and tetracycline, except for the KR20-0408 isolate, which was resistant to tetracycline (Table 1).

Table 1 Antimicrobial susceptibility profiles of 21 NDM-1-producing K. pneumoniae isolates in this study
Full size table

PFGE analysis

All isolates were divided into five different PFGE patterns and were closely related at 95.2% of the minimum similarity value (Fig. 1). Seventeen isolates were clustered together into the KPMX01.568 pattern. Four isolates were divided into four different patterns (KPMX01.347, KPMX01.579, KPMX01.584, and KPMX01.587), differing by only one band.

Fig. 1
figure 1

Molecular epidemiology ofKlebsiella pneumoniaeST147-KL64 isolates possessingblaNDM−1in Korea in 2020

This dendrogram was constructed with BioNumerics (Applied-Maths, Belgium) by utilizing the unweighted-pair group method with arithmetic means and a Dice coefficient (1.5% optimization and 1.5% position tolerance). Strain ID, isolation date, PFGE patterns, MLST, wzi type, antibiotic susceptibility, antimicrobial resistance genes and plasmid replicon types are indicated

Full size image

Genomic analysis

According to the WGS data and MLST scheme of K. pneumoniae, all 21 NDM-1-producing CRKP isolates were identified as ST147 and confirmed to have the same capsular KL64 serotype. Additionally, virulence genes were confirmed to be involved in yersiniabactin (irp1, irp2, ybtAEPQSTUX, and fyuA) and fimbrial adhesion (mrkABCDFHIJ). All 21 ST147-KL64 CRKP isolates coharbored additional resistance determinants, including beta-lactam (blaOXA−1, blaCTX−M−15, blaSHV−11, and blaSHV−67), quinolone (aac(6’)-Ib-cr, qnrS1, OqxA, and OqxB), chloramphenicol (catB3), sulfamethoxazole (sul1), and trimethoprim (dfrA12) resistance genes, as well as mutations in the quinolone resistance-determining regions (QRDRs) of gyrA (S83I) and parC (S80I) (Fig. 1).

Plasmid analysis

According to whole-genome sequence analysis, 21 ST147-KL64 CRKP isolates shared a common genetic structure. The plasmid incompatibility group of the 21 NDM-1-producing ST147 K. pneumoniae included an IncFIB replicon plasmid approximately 54 kb in size (Fig. 2). The representative ST147-KL64 CRKP genome showed that the flanking regions of the blaNDM−1 gene surrounded the insertion sequences ISAba125 and IS630 upstream and downstream of the bleomycin resistance gene (ISAba125-IS630-blaNDM−1-bleMBL). The other resistance region was carried by IS26 and orf477 on the transposon unit orf477-blaCTX−M−15-IS26 (Fig. 2). This plasmid carried other beta-lactamase genes and those conferring resistance to quinolone, chloramphenicol, and sulfamethoxazole. Attempts to transfer these NDM-1-harboring plasmids by conjugation were unsuccessful. However, the long- and short-read sequencing results confirmed that the blaNDM−1 gene was located on the IncFIB replicon plasmid.

Fig. 2
figure 2

Sequence alignment analysis of IncFIBblaNDM−1plasmids

Linear alignment of the sequences of two representative blaNDM−1 harboring K. pneumoniae strains in this study. The gray shaded area indicates the nucleotide similarity between the corresponding genetic loci in each plasmid

Full size image

Clonal relatedness of bacterial isolates

The phylogenetic analysis of SNPs demonstrated that all strains, including 20 reference strains, differed from each other by 2-2247 SNPs. All K. pneumoniae isolates carrying blaNDM were typed as ST147. Notably, 21 ST147-KL64 CRKP isolates from this study were shown to be significant phylogroups with limited SNP (2–27) divergences (Fig. 3). Whole-genome comparison showed that 7 reference strains obtained from clinical samples in Italy and the USA (KP-12Pi, KP-26Pi, KP-135LU, KP-1Pi, AR_0145, AR_0152 and MRSN752165) are closely related, differing by 68–109 SNPs.

Fig. 3
figure 3

Phylogenetic tree compared to NDM-1-producingK. pneumoniaeST147-KL64 strains

The phylogenetic tree was constructed with CSI phylogeny 1.4 (https://cge.cbs.dtu.dk/services/CSIPhylogeny/) using the genome of K. pneumoniae KP5 as a reference

Full size image

Discussion

From 2017 to 2020, the Korean Antimicrobial Resistance Monitoring System for CRE infections reported that K. pneumoniae was the most frequent pathogen (64.3%), followed by Escherichia coli (18%) and Enterobacter cloacae (3.8%); among these pathogens, blaKPC (75.4%) and blaNDM (18%) were the predominant carbapenemase genotypes [2].

The first identification of nosocomial infections associated with NDM-1 producing K. pneumoniae were reported in the Republic of Korea in 2010 [14]. K. pneumoniae was known as one of the causes of nosocomial infections, and it transferred rapidly due to the efficiency of colonization and acquired resistance to antibiotics [15]. In this study, we demonstrate that K. pneumoniae ST147-KL64 isolates harboring blaNDM−1 have spread in a local tertiary care hospital in the Republic of Korea.

Attempts to transfer these NDM-1-harboring IncFIB plasmids by conjugation were unsuccessful, in agreement with the absence of four conjugation modules (oriT, relaxase, type IV coupling protein [T4CP], and T4SS) from their backbone. However, the results showed that both PFGE and SNP analyses results identified genetically highly related isolates (> 95.2% similarity and 2–27 SNPs differences). Therefore, we confirmed that this nosocomial infection was related to the clonal spread of NDM-1 producing K. pneumoniae rather than the horizontal transmission of plasmids.

The draft genomes revealed a shared plasmid backbone (> 99% nucleotide identity) among the NDM-1-producing ST147-KL64 isolates from these nosocomial infections (Fig. 2). The blaNDM−1 gene was encoded on an IncFIB plasmid, although blaNDM−1 was bracketed by two insertion sequences, ISAba125 and IS630, which belong to the IS30 and IS630 families, respectively.

IncFIB plasmids harboring blaNDM−1 were highly homologous with pAR_0145, 7008.20-NDM1 and pM321-NDM1 from K. pneumoniae isolated from the USA, Switzerland and Myanmar (99% nucleotide identity, GenBank accession numbers CP021941, CP082992 and AP018834) [16, 17]. These plasmids shared a common plasmid backbone with our isolates and possessed a multidrug resistance region harboring blaNDM−1.

Incorporating public blaNDM-producing K. pneumoniae ST147 data into the analysis revealed that these isolates formed a single cluster, suggesting the acquisition of blaNDM by a clonally spreading K. pneumoniae ST147-KL64 strain in one hospital. In addition, these isolates have an identical capsular type, plasmid replicon type, resistance determinant set and mobile genetic element set, which may have been introduced from common sources, implying nosocomial transmission. However, the limited acquisition of NDM-1-producing K. pneumoniae ST147-KL64 could not be explained by the spread from humans to humans or contamination of the environment.

An NDM-producing ST147-KL64 clone has been reported annually in other countries, such as the UK, the USA and Italy [18,19,20]. Recently, several cases have demonstrated the prevalence of NDM-producing K. pneumoniae associated with nosocomial infections, including cases in the USA, Pakistan and the Netherlands [9, 20, 21]. A previous study showed that the K. pneumoniae ST147 clone has a global distribution and that it has been responsible for several nosocomial outbreaks worldwide [5].

The emergence of the NDM-1-producing K. pneumoniae ST147-KL64 clone in a local tertiary care hospital is a concern not only for transmission in hospitals but also for the spread of community-acquired transmission. Thus, increased monitoring is necessary to prevent the dissemination of high-risk clones, and adequate infection control measures against the spread of national and transnational infections, especially those targeting underlying mechanisms, are needed.

Conclusions

The results of this study indicated that persistent infections caused by NDM-1-producing K. pneumoniae ST147 occurred in a local tertiary care hospital in the Republic of Korea. Our findings indicate that NDM-1-producing K. pneumoniae ST147 may have been introduced via a common source, implying nosocomial transmission. Therefore, adequate infection control measures are necessary to prevent the further dissemination by nosocomial and endemic transmission.

Data Availability

Not applicable.

Abbreviations

CRE:

Carbapenem-resistant Enterobacterales

NDM:

New Delhi metallo-β-lactamase

CRKP:

Carbapenem-resistant Klebsiella pneumoniae

PFGE:

Pulsed-field gel electrophoresis

WGS:

Whole-genome sequencing

References

  1. Yoon E-J, Yang JW, Kim JO, Lee H, Lee KJ, Jeong SH. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. Future Microbiology. Future Medicine; 2018;13:771–83. Available from: https://doi.org/10.2217/fmb-2018-0022.

  2. Seongjae Joo M, Kim E, Shin J, Kim J, Yoo. Molecular characteristic analysis and antimicrobial resistance of carbapenem-resistant Enterobacteriaceae(CRE) isolates in the Republic of Korea, 2017–2020. Public Health Weekly Report [Internet]. 2021; Available from: https://www.kdca.go.kr/board/board.es?mid=a30501000000&bid=0031&list_no=718138&act=view#.

  3. Coelho A, Mirelis B, Alonso-Tarrés C, Larrosa MN, Miró E, Abad RC et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. Journal of Antimicrobial Chemotherapy. 2009;64:862–4. Available from: https://doi.org/10.1093/jac/dkp264.

  4. Damjanova I, Tóth Á, Pászti J, Hajbel-Vékony G, Jakab M, Berta J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005—the new ‘MRSAs’? Journal of Antimicrobial Chemotherapy. 2008;62:978–85. Available from: https://doi.org/10.1093/jac/dkn287.

  5. Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. 2020. Available from: https://journals.asm.org/journal/aac.

  6. Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrobial agents and chemotherapy. United States. 2015;59:5873–84.

    CAS  Google Scholar 

  7. Gonzales-Escalante E, Ruggiero M, Cerdeira L, Esposito F, Fontana H, Lincopan N, et al. Whole-genome analysis of a high-risk clone of Klebsiella pneumoniae ST147 carrying both mcr-1 and blaNDM–1 genes in Peru. Microbial drug resistance (Larchmont, NY). United States. 2022;28:171–9.

    CAS  Google Scholar 

  8. Marí-Almirall M, Cosgaya C, Pitart C, Viñes J, Muñoz L, Campo I et al. Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions. Journal of Antimicrobial Chemotherapy. 2021;76:345–54. Available from: https://doi.org/10.1093/jac/dkaa459.

  9. Gondal AJ, Saleem S, Jahan S, Choudhry N, Yasmin N. Novel Carbapenem-Resistant Klebsiella pneumoniae ST147 Coharboring blaNDM–1, blaOXA–48 and Extended-Spectrum β-Lactamases from Pakistan. 2020; Available from: https://doi.org/10.2147/IDR.S251532.

  10. Sugawara Y, Akeda Y, Hagiya H, Zin KN, Aye MM, Takeuchi D et al. Characterization of blaNDM–5-harbouring Klebsiella pneumoniae sequence type 11 international high-risk clones isolated from clinical samples in Yangon General Hospital, a tertiary-care hospital in Myanmar. J Med Microbiol Engl; 2021;70.

  11. Pan F, Tian D, Wang B, Zhao W, Qin H, Zhang T, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis Engl. 2019;19:678.

    Article  Google Scholar 

  12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, CLSI supplement M100S. 28th editi. Wayne, PA.: Clinical and Laboratory Standards Institute; 2018.

    Google Scholar 

  13. Khong WX, Marimuthu K, Teo J, Ding Y, Xia E, Lee JJ, et al. Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches. J Antimicrob Chemother Engl. 2016;71:3081–9.

    Article  CAS  Google Scholar 

  14. Mi-Na K, Dongeun Y, Dongheui A, Hae-Sun C, Hee WJ, Kyungwon L et al. Nosocomial Clustering of NDM-1-Producing Klebsiella pneumoniae Sequence Type 340 Strains in Four Patients at a South Korean Tertiary Care Hospital. Journal of Clinical Microbiology. American Society for Microbiology; 2012;50:1433–6. Available from: https://doi.org/10.1128/JCM.06855-11.

  15. Zheng R, Zhang Q, Guo Y, Feng Y, Liu L, Zhang A et al. Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China. Annals of Clinical Microbiology and Antimicrobials. 2016;15:10. Available from: https://doi.org/10.1186/s12941-016-0124-6.

  16. Campos-Madueno EI, Moser AI, Jost G, Maffioli C, Bodmer T, Perreten V, et al. Carbapenemase-producing Klebsiella pneumoniae strains in Switzerland: human and non-human settings may share high-risk clones. J Global Antimicrob Resist Elsevier. 2022;28:206–15.

    Article  CAS  Google Scholar 

  17. Yo S, Yukihiro A, Hideharu H, Noriko S, Dan T, Kumar SR et al. Spreading Patterns of NDM-Producing Enterobacteriaceae in Clinical and Environmental Settings in Yangon, Myanmar. Antimicrobial Agents and Chemotherapy. American Society for Microbiology; 2022;63:e01924-18. Available from: https://doi.org/10.1128/AAC.01924-18.

  18. Conlan S, Lau AF, Program NCS, Palmore TN, Frank KM, Segre JA. Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying blaNDM–1 on a Multidrug Resistance Plasmid. Genome announcements. American Society for Microbiology; 2016;4:e00664-16. Available from: https://pubmed.ncbi.nlm.nih.gov/27417839.

  19. Falcone M, Giordano C, Barnini S, Tiseo G, Leonildi A, Malacarne P, et al. Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020. Eurosurveillance. European Centre for Disease Prevention and Control (ECDC); 2020. p. 25.

  20. Lapp Zena C, Ryan M-J, Arianna P, Ali, Trick William E, Weinstein Robert A et al. Regional Spread of blaNDM–1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities. Clinical Infectious Diseases. 2021;73:1431–9. Available from: https://doi.org/10.1093/cid/ciab457.

  21. Thijs Bosch SPM, Lutgens MHA, Hermans, Peter C, Wever, Peter M, Schneeberger, Nicole HM, Renders et al. Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers. Journal of Clinical Microbiology. American Society for Microbiology; 2017;55:2380–90. Available from: https://doi.org/10.1128/JCM.00535-17.

Download references

Funding

This work was supported by a grant from the Korea Disease Control and Prevention Agency (grant number 4847-311-210).

Author information

Authors and Affiliations

  1. Division of Bacterial Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, Republic of Korea

    Jungsun Park, Eunkyung Shin, Min-Kyeong Kim, Seongjae Joo, Hyun Ju Jeong, Jaeil Yoo & Junyoung Kim

  2. Division of Infectious Diseases Research, Gyeongsangbuk-do Metropolitan Government Research Institute of Public Health and Environment, Gyeongsangbuk-do, Republic of Korea

    Gwang Rip Hwang

  3. Infectious Diseases Team, Seoul Metropolitan Government Research Institute of Public Health and Environment, Gwacheon-si, Gyeonggi-do, Republic of Korea

    Jin Seok Kim

Authors
  1. Jungsun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eunkyung Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gwang Rip Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min-Kyeong Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seongjae Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hyun Ju Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jin Seok Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jaeil Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Junyoung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JP and JuK conceived of the study and participated in its design and draft the manuscript. M-kK, SJ and HJ collected samples and identified isolates. JP carried out the experiments and analyzed the data. ES, JSK, and JiY contributed to experiment conception. All authors contributed to the article and approved the submitted version.

Corresponding author

Correspondence to Junyoung Kim.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12941_2023_601_MOESM1_ESM.doc

Supplementary data: Table S1. List of the GenBank-archived K. pneumoniae ST147 strains under analysis and Bacterial stains used in this study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, J., Shin, E., Hwang, G.R. et al. Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea. Ann Clin Microbiol Antimicrob 22, 76 (2023). https://doi.org/10.1186/s12941-023-00601-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12941-023-00601-2

Keywords

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us